SCHEMBL427693

SCHEMBL427693

O=C(Cl)n1cccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14385408 0.79 NOS1 (0.52)
SCHEMBL1021803 0.79 NOS1 (0.52)
SCHEMBL6560854 0.77
SCHEMBL128493 0.77
SCHEMBL946317 0.76 NOS1 (0.56)
SCHEMBL1275 0.75
SCHEMBL4521551 0.75
SCHEMBL1868722 0.75
SCHEMBL1680220 0.75
Hydrochloric Acid SCHEMBL11561704 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2104663-B1 METHOD FOR PRODUCING SUBSTITUTED PYRAZOLECARBOXYLIC ACID CHLORIDES BAYER IP GMBH (DE) 2015-07-15 EP claimed
US-7977494-B2 Method for producing substituted pyrazolecarboxylic acid chlorides BAYER CROPSCIENCE AG (DE) 2011-07-12 US claimed
US-20100041899-A1 METHOD FOR PRODUCING SUBSTITUTED PYRAZOLECARBOXYLIC ACID CHLORIDES BAYER CROP SCIENCE AG (DE) 2010-02-18 US claimed
JP-62010066-A None JP disclosed
EP-4696688-A1 BENZO-FUSED RING COMPOUND INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Hansoh Biomedical Co., Ltd. (CN) 2026-02-18 EP disclosed
EP-4055021-B1 HETEROCYCLIC RIP1 INHIBITORY COMPOUNDS RIGEL PHARMACEUTICALS INC (US) 2025-10-08 EP disclosed
CN-114728918-B RIP1 inhibitory compounds and methods of making and using the same 里格尔药品股份有限公司 2025-06-17 CN disclosed
US-12331036-B2 Heterocyclic RIP1 kinase inhibitors RIGEL PHARMACEUTICALS, INC. (US) 2025-06-17 US disclosed
EP-4025568-B1 RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME RIGEL PHARMACEUTICALS INC (US) 2025-05-14 EP disclosed
EP-4025574-B1 RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME RIGEL PHARMACEUTICALS INC (US) 2025-05-07 EP disclosed
EP-4025572-B1 HETEROCYCLIC RIP1 KINASE INHIBITORS RIGEL PHARMACEUTICALS INC (US) 2025-05-07 EP disclosed
US-20100041899-A1 METHOD FOR PRODUCING SUBSTITUTED PYRAZOLECARBOXYLIC ACID CHLORIDES BAYER CROP SCIENCE AG (DE) 2010-02-18 US disclosed
US-20100029478-A1 ANTHRANILIC ACID DIAMIDE DERIVATIVE WITH HETERO-AROMATIC AND HETERO-CYCLIC SUBSTITUENTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2010-02-04 US disclosed
CN-1317280-C Novel diazabicyclic aryl derivatives NEUROSEARCH AS (DK) 2007-05-23 CN disclosed
EP-0569505-B1 3-DIFLUOROMETHYLPYRAZOLECARBOXAMIDE FUNGICIDES MONSANTO CO (US) 1994-12-07 EP disclosed
EP-0569505-A1 3-DIFLUOROMETHYLPYRAZOLECARBOXAMIDE FUNGICIDES. MONSANTO CO (US) 1993-11-18 EP disclosed
WO-1992012970-A1 3-DIFLUOROMETHYLPYRAZOLECARBOXAMIDE FUNGICIDES MONSANTO COMPANY (US) 1992-08-06 WO disclosed
US-5093347-A Alleviating infections in diseased plants MONSANTO COMPANY (US) 1992-03-03 US disclosed
JP-S6210066-A PYRAZOLECARBOXAMIDE DERIVATIVE AND GERMICIDE CONTAINING SAID DERIVATIVE AS ACTIVE CONSTITUENT SUMITOMO CHEM CO LTD 1987-01-19 JP disclosed
US-4153710-A HYPOGLYCEMIC AGENTS STAROGARDZKIE ZAKLADY FARMACEUTYCZNE POLFA (PL) 1979-05-08 US disclosed